Pharmalot - STAT

Pharmalot By Ed Silverman

Senators urge bankruptcy judge to prevent Purdue from paying its CEO a $3.5 million bonus

Pharmalot By Ed Silverman

Pharmalittle: Azar bars FDA from signing new rules; AstraZeneca reveals Covid-19 vaccine trial protocol

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Roche says its drug helped Covid-19 patients; Trump expected to finalize drug importation plan

Pharmalot By Ed Silverman

State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”

Pharmalot By Ed Silverman

Pharmalittle: Biden-aligned group releases drug-pricing plan; U.S. to ship Covid-19 vaccines lickety-split

Opioid photo illustration opioid overdose

Pharmalot By Ed Silverman

Court rules New York can collect taxes from drug makers and wholesalers to address opioid crisis

Pharmalot By Ed Silverman

FDA warns Sprout for failing to mention risks in radio ad for Addyi

Pharmalot By Ed Silverman

Pharmalittle: Gates is ‘dumbfounded’ by U.S. Covid-19 response; WHO urges countries to join COVAX

Pharmalot By Ed Silverman

Pharmalittle: Gilead to pay $21 billion to buy Immunomedics; Trump releases executive order on drug pricing

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: NIH to test blood thinners against Covid-19; AbbVie employees feel pressured to return to work

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca hopes for Covid-19 vaccine results by year-end; fewer Americans trust the CDC

Pharmalot By Ed Silverman

The Pony Express? U.S. Postal Service changes continue to slow down deliveries of mail-order prescriptions

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca pauses its Covid-19 vaccine trial; FDA sticking with its vaccine approval guidelines

Pharmalot By Ed Silverman

Drug and device makers paid teaching hospitals $832 million in 2018, creating potential for conflicts of interest

Pharmalot By Ed Silverman

Pharmalittle: Covid-19 vaccine makers pledge to prioritize safety and efficacy; is Operation Warp Speed working?

Pharmalot By Ed Silverman

A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents

Pharmalot By Elizabeth Cooney

Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: States asked to speed Covid-19 vaccine distribution sites; NIH panel contradicts FDA on plasma

Pharmalot By Ed Silverman

Pharmalittle: U.S. won’t join WHO Covid-19 vaccine program; experts say a vaccine is possible this fall

Pharmalot By Ed Silverman

FDA cites Mylan for ‘repeated failures’ at manufacturing plants in India

Pharmalot By Ed Silverman

Congressional committee to subpoena AbbVie in drug pricing investigation

Pharmalot By Ed Silverman

Most Read

The cost of Gilead’s HIV prevention pill thwarted widespread use, study finds

‘Everyone was left to guess what went wrong’: An open letter to AstraZeneca’s CEO on transparency

Pharma drew a line in the sand over Covid-19 vaccine readiness — because someone had to

‘An unchartered situation for all of us’: From shipping containers to security concerns, a Covid-19 vaccine supply chain takes shape

Novartis and Roche are fined $528 million for anti-competitive practices in France

A Pennsylvania lawmaker wants to tie prescription drug prices to what Canada pays

Lawmakers demand drug makers stop threatening to end discounts for safety-net hospitals

Pharmalittle: Lilly drug helped Covid-19 patients; FDA confirms AstraZeneca vaccine trial is on hold

All Coverage

Senators urge bankruptcy judge to prevent Purdue from paying its CEO a $3.5 million bonus

Pharmalittle: Azar bars FDA from signing new rules; AstraZeneca reveals Covid-19 vaccine trial protocol

Up and down the ladder: The latest comings and goings

Pharmalittle: Roche says its drug helped Covid-19 patients; Trump expected to finalize drug importation plan

State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”

Pharmalittle: Biden-aligned group releases drug-pricing plan; U.S. to ship Covid-19 vaccines lickety-split

Court rules New York can collect taxes from drug makers and wholesalers to address opioid crisis

FDA warns Sprout for failing to mention risks in radio ad for Addyi

Pharmalittle: Gates is ‘dumbfounded’ by U.S. Covid-19 response; WHO urges countries to join COVAX

Pharmalittle: Gilead to pay $21 billion to buy Immunomedics; Trump releases executive order on drug pricing

Up and down the ladder: The latest comings and goings

Pharmalittle: NIH to test blood thinners against Covid-19; AbbVie employees feel pressured to return to work

Pharmalittle: AstraZeneca hopes for Covid-19 vaccine results by year-end; fewer Americans trust the CDC

The Pony Express? U.S. Postal Service changes continue to slow down deliveries of mail-order prescriptions

Pharmalittle: AstraZeneca pauses its Covid-19 vaccine trial; FDA sticking with its vaccine approval guidelines

Drug and device makers paid teaching hospitals $832 million in 2018, creating potential for conflicts of interest

Pharmalittle: Covid-19 vaccine makers pledge to prioritize safety and efficacy; is Operation Warp Speed working?

A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents

Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?

Up and down the ladder: The latest comings and goings

Pharmalittle: States asked to speed Covid-19 vaccine distribution sites; NIH panel contradicts FDA on plasma

Pharmalittle: U.S. won’t join WHO Covid-19 vaccine program; experts say a vaccine is possible this fall

FDA cites Mylan for ‘repeated failures’ at manufacturing plants in India

Congressional committee to subpoena AbbVie in drug pricing investigation

Pharmalittle: Sanofi drug fails to tackle serious Covid-19 cases; EC agrees to fund WHO Covax program